These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3562857)

  • 1. 32P-postlabeling assay to measure carcinogen-DNA adducts.
    Gupta RC
    Prog Exp Tumor Res; 1987; 31():21-32. PubMed ID: 3562857
    [No Abstract]   [Full Text] [Related]  

  • 2. High-performance liquid chromatographic analysis of 32P-postlabeled DNA-aromatic carcinogen adducts.
    Levy GN; Weber WW
    Anal Biochem; 1988 Nov; 174(2):381-92. PubMed ID: 3239743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 32P-postlabeling assay for carcinogen-DNA adducts and other dna modifications.
    Randerath K; Randerath E
    J UOEH; 1989 Mar; 11 Suppl():368-86. PubMed ID: 2664950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring carcinogen actions on DNA by 32P-postlabeling.
    Randerath K; Randerath E
    Princess Takamatsu Symp; 1990; 21():317-28. PubMed ID: 2134685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 32P-postlabeling and HPLC-FD analysis of DNA adducts in rats acutely exposed to benzo(a)pyrene.
    Godschalk RW; Vermeer IT; Kriek E; Floot B; Schilderman PA; Moonen EJ; Kleinjans JC; van Schooten FJ
    Chem Biol Interact; 1997 Apr; 104(1):41-54. PubMed ID: 9158694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemical, 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation.
    Culp SJ; Roberts DW; Talaska G; Lang NP; Fu PP; Lay JO; Teitel CH; Snawder JE; Von Tungeln LS; Kadlubar FF
    Mutat Res; 1997 Aug; 378(1-2):97-112. PubMed ID: 9288889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 32P-postlabeling test for covalent DNA binding of chemicals in vivo: application to a variety of aromatic carcinogens and methylating agents.
    Reddy MV; Gupta RC; Randerath E; Randerath K
    Carcinogenesis; 1984 Feb; 5(2):231-43. PubMed ID: 6697441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postlabeling methods for carcinogen-DNA adduct analysis.
    Randerath K; Randerath E; Agrawal HP; Gupta RC; Schurdak ME; Reddy MV
    Environ Health Perspect; 1985 Oct; 62():57-65. PubMed ID: 3910421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 32P-postlabeling DNA damage assays: PAGE, TLC, and HPLC.
    Shibutani S; Kim SY; Suzuki N
    Methods Mol Biol; 2006; 314():307-21. PubMed ID: 16673890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclease S1-mediated enhancement of the 32P-postlabeling assay for aromatic carcinogen-DNA adducts.
    Reddy MV
    Carcinogenesis; 1991 Sep; 12(9):1745-8. PubMed ID: 1893535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 32P-postlabeling analysis of DNA adducts in rat livers after treatment with genotoxic and non-genotoxic 4-aminoazobenzene derivatives.
    Kojima M; Degawa M; Hashimoto Y; Tada M
    Cancer Lett; 1991 Jul; 58(3):199-204. PubMed ID: 1855196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA adduct formation after oral administration of 2-nitrofluorene and N-acetyl-2-aminofluorene, analyzed by 32P-TLC and 32P-HPLC.
    Möller L; Zeisig M
    Carcinogenesis; 1993 Jan; 14(1):53-9. PubMed ID: 8425271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new sensitive 32P-postlabeling assay based on the specific enzymatic conversion of bulky DNA lesions to radiolabeled dinucleotides and nucleoside 5'-monophosphates.
    Randerath K; Randerath E; Danna TF; van Golen L; Putman KL
    Carcinogenesis; 1989 Jul; 10(7):1231-9. PubMed ID: 2544310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 32P-postlabeling analysis of non-radioactive aromatic carcinogen--DNA adducts.
    Gupta RC; Reddy MV; Randerath K
    Carcinogenesis; 1982; 3(9):1081-92. PubMed ID: 7139866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influences of DNA isolation and RNA contamination on carcinogen-DNA adduct analysis by 32P-postlabeling.
    Godschalk RW; Maas LM; Kleinjans JC; Van Schooten FJ
    Environ Mol Mutagen; 1998; 32(4):344-50. PubMed ID: 9882009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of human DNA adducts by 32P-postlabeling.
    Randerath K; Randerath E
    Basic Life Sci; 1990; 53():13-32. PubMed ID: 2282030
    [No Abstract]   [Full Text] [Related]  

  • 17. 32P-postlabeling assay for carcinogen-DNA adducts: description of beta shielding apparatus and semi-automatic spotting and washing devices that facilitate the handling of multiple samples.
    Reddy MV; Blackburn GR
    Carcinogenesis; 1990 Apr; 11(4):683-7. PubMed ID: 2323007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different responses other than the formation of DNA-adducts between the livers of carcinogen-resistant rats (DRH) and carcinogen-sensitive rats (Donryu) to 3'-methyl-4-dimethylaminoazobenzene administration.
    Yan Y; Higashi K; Yamamura K; Fukamachi Y; Abe T; Gotoh S; Sugiura T; Hirano T; Higashi T; Ichiba M
    Jpn J Cancer Res; 1998 Aug; 89(8):806-13. PubMed ID: 9765615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 32P-postlabeling analysis of DNA adducts.
    Phillips DH; Hewer A; Arlt VM
    Methods Mol Biol; 2005; 291():3-12. PubMed ID: 15502206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and quantitation of dG-AAI and dA-AAI adducts by 32P-postlabeling methods in urothelium and exfoliated cells in urine of rats treated with aristolochic acid I.
    Fernando RC; Schmeiser HH; Nicklas W; Wiessler M
    Carcinogenesis; 1992 Oct; 13(10):1835-9. PubMed ID: 1423842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.